Development and validation of the diabetes quality of life clinical trial questionnaire

Medical Care

Volumn 37, Issue 4 SUPPL. 1, 1999, Pages

  Shen, Wei ^a   Kotsanos, James G ^a   Huster, William J ^a   Mathias, Susan D ^b   Andrejasich, Carol M ^a   Patrick, Donald L ^c  

^a ELI LILLY AND COMPANY   (United States)

^b Lewin TAG Inc   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Clinical trials; Diabetes; Quality of life; Reliability; Responsiveness; Validity

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; INSULIN LISPRO;

ADULT; ARTICLE; CANADA; CLINICAL TRIAL; FEMALE; FRANCE; GERMANY; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; UNITED STATES;

ADULT; CANADA; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOCUS GROUPS; FRANCE; GERMANY; HEALTH STATUS INDICATORS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MULTICENTER STUDIES; PILOT PROJECTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 0033112124     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199904001-00008     Document Type: Article

References (27)

1. Croog S, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986;314:1657.
2. Patrick DL, Erickson P. Health status and health policy: Quality of life in health care evaluation and resource allocation. New York: Oxford University Press, 1993:20.
3. Pocock SJ. A perspective on the role of quality-of-life assessment in clinical trials. Controlled Clin Trials 1991;12:257S.
4. Eiser C, Tooke JE. Quality-of-life evaluation in diabetes. PharmacoEconomics 1993;4:85.
5. Waadt, Duran G, Waadt M, Herschbach P, Strian F. Quality of life in patients with type II diabetes mellitus. In: Lefébvre PJ, Stabdl E, eds. New aspects in diabetes. Berlin: Walter de Gruyter, 1992:111.
6. Tallroth G, Karlson B, Nilsson A, Agardh C. The influence of different insulin regimen on quality of life and metabolic control in insulin-dependent diabetes. Diabet Res Clin Prac 1989;6:37.
7. Bradley C, Gamsu DS. Guidelines for encouraging psychological well being: Report of a working group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 1994;11:510.
8. DCCT Research Group. Reliability and validity of a diabetes quality of life measure for the Diabetes Control and Compliance Trial (DCCT). Diabet Care 1988;11:725.
9. Jacobsom AM. The Diabetes Quality of Life measure. In: Bradley C, ed. Handbook of psychology and diabetes. Switzerland: Hardwood and Academic Publishers, 1994:65.
10. Kotsanos JG, Vignati L, Huster W, Andrejasich C, Boggs MB, Jaconson AM, et al. Health related quality of life results from multinational clinical trials of insulin lispro: Assessing benefits of a new diabetes therapy. Diabet Care 1997;20:948.
11. Streiner DL, Norman GR. Health measurement scale: A practical guide to their development and use. Oxford: Oxford University Press, 1989.
12. McDowell I, Newell C. Measuring health: A guide for rating scale and questionnaire. New York: Oxford University Press, 1987.
13. Brook RH, Ware JE, Davies-Avery A, Stewart AL, Donald CA, Rogers WH, et al. Overview of adult health status fielded in Rand's Health Insurance Study. Med Care 1979;17(suppl):1.
14. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: Manual and interpretation guide. Boston: The Health Institute, 1993.
15. Stewart AL, Ware JE, eds. Measuring functioning and well-being: The medical outcomes study approach. Durham: Duke University Press, 1992.
16. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: Qualification, validation, and utilization. Diabet Care 1987;10:617.
17. Dillman D. Mail and telephone surveys. New York: John Wiley and Sons, 1978.
18. Guyatt GH. The philosophy of health-related quality of life translation. Qual Life Res 1993;2:461.
19. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297.
20. Nunnally JC, Berstein IH. Psychometric theory. 3rd Ed. New York: McGraw-Hill, 1994.
21. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: Statistics and strategics for evaluation. Controlled Clin Trials 1991;12:142S.
22. SAS Institute Inc. SAS procedures guide. Version 6. 3rd Ed. Cary: SAS Institute, 1990.
23. Slevin MR, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988;57:109.
24. Parkerson GR, Connie RT, Broadhead WE, Patrick DL, Taylor TR, Tse CJ. Disease-specific versus generic measurement of health-related quality life in insulin-dependent diabetic patients. Med Care 1993;31:629.
25. Hanestad BR, Hornquist JO, Albrektsen G. Self-assessed quality of life and metabolic control in persons with insulin-dependent diabetes mellitus (IDDM). Scand J Soc Med 1991;19:57.
26. Mazze RS, Lucido D, Shamoon H. Psychological and social correlates of glycemic control. Diabet Care 1984;7:360.
27. Nerenz DR, Repasky DP, Whitehouse FW, Kahonen DM. Ongoing assessment of health status in patients with diabetes mellitus. Med Care 1992;30(suppl):112.